CompletedNCT04503954
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaPlacebo comparisonAges 20–99
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
TerminatedNCT03230864
Efficacy of Lu AF35700 in people with Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
What is this study about?
This study evaluates the effectiveness of Lu AF35700 for people with schizophrenia.
This study ended early.
Multiple locations, including San DiegoSchizophreniaMedication studyAges 18+
CompletedNCT03891186
Efficacy of Metacognitive Training for Schizophrenia - a Study Protocol
Official study title
A Randomized Controlled Trial to Evaluate the Efficacy of Metacognitive Training for Schizophrenia Applied by Mental Health Nurses: Study Protocol
This study has finished and is no longer accepting participants.
In PortalegreSchizophreniaBehavioural studyAges 18–65
CompletedNCT02748486
Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize...
Official study title
Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... Among Patients of Psychiatric Rehabilitation Ward With Diagnosis of Schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaBehavioural studyAges 18+
CompletedNCT01279070
Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia
Official study title
Efficacy of Repyflec Cognitive Remediation Group Training in Cognition, Functional Outcomes and Psychiatric Symptoms of Outpatients With Schizophrenia.
This study has finished and is no longer accepting participants.
In Sant Boi de LlobregatSchizophreniaBehavioural studyAges 18–60
CompletedNCT02110771
Efficacy Study of GAÏA Program Cognitive Remediation of Facial Affects Processing in Schizophrenia
This study has finished and is no longer accepting participants.
In LyonSchizophreniaBehavioural studyAges 18–45
CompletedNCT01393613
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
What is this study about?
Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
CompletedNCT02477670
Efficacy, Safety, and Tolerability of AVP-786 for Residual Schizophrenia
What is this study about?
This study evaluated the safety and effectiveness of AVP-786 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosSchizophreniaMedication studyAges 18–60
CompletedNCT01668797
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
What is this study about?
Researchers compared Brexpiprazole and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–65
CompletedNCT01488929
Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
What is this study about?
This study evaluated the safety and effectiveness of TC-5619 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveSchizophreniaMedication studyAges 18–65
CompletedNCT02667834
Efficiency of the French Translation Social Cognition and Interactive Training (SCIT)Program
Official study title
Efficiency of the French Translation Program:Social Cognition and Interactive Training (SCIT) of Negative Symptoms in Schizophrenia
This study has finished and is no longer accepting participants.
In ClermontSchizophreniaBehavioural studyAges 18–50
CompletedNCT01516424
Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
What is this study about?
Researchers compared Blonanserin and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingSchizophreniaMedication studyAges 18–64
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.